Page 4 - Nasdaq Hrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq hrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Hrow Today - Breaking & Trending Today

Harrow Health, Inc. (NASDAQ:HROW) Shares Sold by Corrado Advisors LLC

Corrado Advisors LLC lessened its holdings in shares of Harrow Health, Inc. (NASDAQ:HROW – Get Rating) by 14.9% during the fourth quarter, HoldingsChannel reports. The fund owned 16,314 shares of the company’s stock after selling 2,846 shares during the period. Corrado Advisors LLC’s holdings in Harrow Health were worth $241,000 at the end of the […] ....

United States , Dimensional Fund Advisors , Eton Pharmaceuticals Inc , Harrow Health Inc , Surface Ophthalmics Inc , Corrado Advisors , Citigroup Inc , Harrow Health Company Profile , Pharmaceuticals Inc , B Riley Financial Inc , Harrow Health Stock Performance , Quarter For Harrow Health , News Ratings For Harrow Health Daily , Harrow Health , Get Rating , Fund Advisors , Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Visit Holdingschannel , Harrow Health Daily , Nasdaq Hrow , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Harrow Health (HROW) Scheduled to Post Earnings on Thursday

Harrow Health (NASDAQ:HROW – Get Rating) is scheduled to release its earnings data after the market closes on Thursday, May 11th. Analysts expect Harrow Health to post earnings of ($0.05) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Harrow Health Stock Up […] ....

United States , Earnings History For Harrow Health , Harrow Health , Surface Ophthalmics Inc , News Ratings For Harrow Health Daily , Eton Pharmaceuticals Inc , Pharmaceuticals Inc , Cubist Systematic Strategies , American Century Companies Inc , America Corp , Harrow Health Inc , Harrow Health Company Profile , Hedge Funds Weigh In On Harrow Health , Harrow Health Stock , Get Rating , Street Capital , Systematic Strategies , Century Companies , Jane Street Group , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,

Harrow Health (NASDAQ:HROW) Hits New 1-Year High at $28.25

Harrow Health, Inc. (NASDAQ:HROW – Get Rating)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $28.25 and last traded at $26.89, with a volume of 77630 shares. The stock had previously closed at $28.08. Analyst Upgrades and Downgrades A number of brokerages have recently issued […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Pharmaceuticals Inc , Dorsey Wright Associates , Tower Research Capital , Institutional Investors Weigh In On Harrow Health , Northwestern Mutual Wealth Management Co , Barclays Plc , Harrow Health Price Performance , News Ratings For Harrow Health Daily , Harrow Health Inc , Harrow Health , Eton Pharmaceuticals Inc , Surface Ophthalmics Inc , Get Rating , Street Capital , Kantonalbank Zurich Cantonalbank , Mutual Wealth Management , Research Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,

B. Riley Reaffirms "Buy" Rating for Harrow Health (NASDAQ:HROW)

B. Riley reissued their buy rating on shares of Harrow Health (NASDAQ:HROW – Get Rating) in a research note published on Thursday, PriceTargets.com reports. B. Riley also issued estimates for Harrow Health’s FY2026 earnings at $4.27 EPS and FY2027 earnings at $6.22 EPS. A number of other analysts also recently issued reports on the stock. […] ....

Harrow Health Inc , Harrow Health Stock , Harrow Health Company Profile , Tower Research Capital , Dorsey Wright Associates , Eton Pharmaceuticals Inc , Barclays Plc , Pharmaceuticals Inc , Surface Ophthalmics Inc , Northwestern Mutual Wealth Management Co , Harrow Health , News Ratings For Harrow Health Daily , Institutional Trading Of Harrow Health , Get Rating , Street Capital , Mutual Wealth Management , Research Capital , Captrust Financial Advisors , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Reiterated Rating , B Riley ,

B. Riley Reaffirms "Buy" Rating for Harrow Health (NASDAQ:HROW)

B. Riley reaffirmed their buy rating on shares of Harrow Health (NASDAQ:HROW – Get Rating) in a research note published on Thursday morning, PriceTargets.com reports. B. Riley also issued estimates for Harrow Health’s FY2026 earnings at $4.27 EPS and FY2027 earnings at $6.22 EPS. HROW has been the subject of several other reports. Lake Street […] ....

News Ratings For Harrow Health Daily , Dorsey Wright Associates , Northwestern Mutual Wealth Management Co , Surface Ophthalmics Inc , Tower Research Capital , Harrow Health Price Performance , Harrow Health , Harrow Health Inc , Hedge Funds Weigh In On Harrow Health , Barclays Plc , Pharmaceuticals Inc , Eton Pharmaceuticals Inc , Get Rating , Street Capital , Mutual Wealth Management , Research Capital , Captrust Financial Advisors , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Reiterated Rating , B Riley ,